Clinical Fellowship Award Program
Building the next generation of amyloidosis physicians.
Application Period is Now Closed.
The Amyloidosis Research Consortium’s (ARC) Clinical Fellowship program supports the education and development of amyloidosis specialists with the aim of growing the base of clinicians who can provide expert care and lead scientific advances.
The program funds U.S. academic centers to build the skills and expertise of an amyloidosis clinician-researcher over a one-year period.
Deadline for Center Applications
Committee Review Complete
Notification to Applicants
Fellow Start Date
December 15, 2024
January 10, 2025
January 15, 2025
Summer 2025
Eligibility Criteria and Funding
The ARC Fellowship Program is open to established amyloidosis centers in the United States to support the training of promising MD fellowship applicants. Fellow should be 75% clinical practice and 25% research focused.
ARC will award up to eight one-year fellowships for a maximum of $120,000 each for fellow support. Each fellow will be awarded an additional sum to participate in at least two training opportunities (conferences, coursework, etc.). No indirect or overhead costs may be claimed.
ARC will also seek opportunities for fellows to network at key meetings/conferences, as well as participating in the annual Amyloidosis Forum.
ARC provides funding directly to qualified centers which then identify the most competitive fellowship candidates. Once fellowship candidates are selected, their credentials will be submitted to ARC for final review and approval. Funding will be released once the fellow has been approved by ARC’s review committee. The fellow selected by the mentor must hold an MD, DO or equivalent degree, be licensed to practice medicine in the U.S. and plan on practicing medicine in the U.S. following the fellowship. Fellows must be newly selected and not previously enrolled in similar programs.
Individual fellows are not eligible for this funding but are encouraged to inform institutions about this opportunity.
ARC will award up to eight one-year fellowships for a maximum of $120,000 each for fellow support. Each fellow will be awarded an additional sum to participate in at least two training opportunities (conferences, coursework, etc.). No indirect or overhead costs may be claimed.
Amyloidosis center applications will be evaluated on the following criteria:
- Academic institution with established amyloidosis expertise and fellowship program, capable of providing a comprehensive, multidisciplinary training experience
- Demonstrated excellence in amyloidosis care and research with multidisciplinary team capabilities
- A dedicated mentor who is actively involved in the training program
- Commitment to support a fellow with the necessary resources and opportunities for a comprehensive training experience
- Leadership in promoting and integrating an equitable and diverse environment for clinical care, research and education through training opportunities for the fellow
- Competence in delivering care that addresses the holistic needs of patients affected by amyloidosis
An external review panel and ARC staff will evaluate applications based on the overall quality of the fellowship program, including the effectiveness of training, mentorship and achievement of learning objectives.
Fellows and their mentors are required to provide a quarterly report of the fellowship training experience and a financial report of expenditures. An overall year-end report will be due 30 days after the completion of the training program.
Reporting forms will be provided by ARC.
Applicant Instructions
Please thoroughly review all documents before submitting. Applications will only be accepted through submission to the following email: clinicalfellowship@arci.org
- Using the application template provided, please give a brief description of the training opportunities available at your center, both in clinical care and research.
- Include the following attachments along with the application template:
- Biographical sketch of the mentor
- Letter of reference
- Completed budget (salary and education opportunities)
- Graphics/Table outlining clinical care rotation and research opportunity requirements
All applications will be treated confidentially and reviewed by ARC staff and external peer reviewers to determine fit with fellowship goals.
U.S. academic centers with established amyloidosis expertise and fellowship program. Centers should have multidisciplinary team capabilities, including but not limited to cardiology, hematology, and neurology. Centers must have a dedicated mentor.
Individual fellows are not eligible for this funding but are encouraged to inform institutions about this opportunity.
The fellow selected by the mentor must hold an MD, DO, or equivalent degree, be licensed to practice medicine in the United States and plan on practicing medicine in the U.S. following the fellowship.
- Download the application template
- Include the following attachments along with the application template:
- Biographical sketch of the mentor
- Letter of reference
- Completed budget (salary, benefits, educational opportunities, etc.)
- Graphics/Table outlining clinical care rotation and research opportunity requirements
Eight academic centers will be selected based on the review criteria listed below. ARC will not award funding to more than one fellow per academic center.
- Academic institution with established amyloidosis expertise and fellowship program, capable of providing a comprehensive training experience
- Demonstrated excellence in amyloidosis care and research with multidisciplinary team capabilities
- Centers must have a dedicated mentor
- Commitment to support a fellow with the necessary resources and opportunities for a comprehensive training experience
- Leadership in promoting and integrating an equitable and diverse environment for clinical care, research and education through training opportunities for the fellow
- Competence in delivering care that addresses the holistic needs of patients affected by amyloidosis
ARC will award up to eight one-year fellowships for a maximum of $120,000 each for fellow support. Each fellow will be awarded an additional sum to participate in at least two training opportunities (conferences, coursework, etc.). No indirect or overhead costs may be claimed.
This activity is supported by an independent educational grant from AstraZeneca and Ionis Pharmaceuticals.
